Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
Is Gilead Sciences Its Own Worst Enemy?

Gilead's science is so good that it's actually destroying the company's business. Pharma companies, like most other businesses, make the bulk of their money through repeat business. Gilead, however, is doing something really no other drugmaker is doing -- namely curing patients of devastating infectious diseases.

Published
20 May 2015
From
Motley Fool
Statin use associated with lower risk of liver decompensation and death in hepatitis C patients with cirrhosis

People with hepatitis and liver cirrhosis were significantly less likely to progress to decompensated disease and less likely to die if they used statins to control blood

Published
19 May 2015
By
Liz Highleyman
If I'm Cured of Hepatitis C, When Is It Safe to Drink Again?

Doctors say the answer lies in whether a patient is honest about their alcohol use and how much damage the liver sustained before treatment.

Published
19 May 2015
From
Healthline
Investing in hepatitis C drugs could save the economy billions, researchers suggest

Researchers who examined the effect of treating hepatitis C patients with the newer generation of oral drugs suggest while these medications may cost tens of thousands of dollars for a 12-week course, they could avert billions in lost productivity.

Published
19 May 2015
From
Medical News Today
Civacir immune globulin may help prevent HCV reinfection after liver transplant

Civacir, a hepatitis C immune globulin or antibody product, reduced the likelihood of hepatitis C virus infecting the new liver graft after transplantation in people who were

Published
17 May 2015
By
Liz Highleyman
Gilead triple combination cures easy-to-treat hepatitis C patients in 6 weeks, but 4 weeks is not enough

A six-week regimen of sofosbuvir (Sovaldi) plus two experimental direct-acting antivirals being developed by Gilead Sciences cured more than 90% of previously untreated people with genotype 1 hepatitis

Published
15 May 2015
By
Liz Highleyman
Shortening hepatitis C treatment to 6 weeks effective but not perfect for easier-to-treat patients

Shortening hepatitis C treatment to 6 weeks for easier-to-treat patients without cirrhosis does not greatly reduce the efficacy of hepatitis C treatment for people with genotype 1

Published
15 May 2015
By
Keith Alcorn
The VA's Hepatitis C Problem

Approximately 174,000 veterans in government care have been diagnosed with hepatitis C. For treatment, those veterans who know they are sick must go to the U.S. Department of Veterans Affairs (VA) and its health care services extension: the Veterans Health Administration (VHA), the largest provider of hepatitis C care in the nation. The VHA serves nearly 9 million patients at over 1,700 sites, but as Dames and many other veterans have found, treatment there is often amiss—especially when it comes to HCV.

Published
14 May 2015
From
Newsweek
Starved T cells allow hepatitis B to silently infect liver

Hepatitis B stimulates processes that deprive the body’s immune cells of key nutrients that they need to function, finds new UCL-led research funded by the Medical Research Council and Wellcome Trust. The work helps to explain why the immune system cannot control hepatitis B virus infection once it becomes established in the liver, and offers a target for potential curative treatments down the line.

Published
14 May 2015
From
University College London press release
Philip Christopher Baldwin talks about living with hep C in the gay community

I did not have the courage to tell people that I had Hep C, worried that others would gossip about me. There were no role models in the media for co-infection with HIV and Hep C, which made it harder to be open. I had fought so hard to be an out gay man, and now I was hiding something that was inextricably linked to my sexuality, to my identity and to my core sense of who I am.

Published
13 May 2015
From
QX

Filter by country